- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Deptor: not only a mTOR inhibitor ; volume:36 ; number:1 ; day:13 ; month:1 ; year:2017 ; pages:1-9 ; date:12.2017
Journal of experimental & clinical cancer research ; 36, Heft 1 (13.1.2017), 1-9, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Catena, Valeria
- Beteiligte Personen und Organisationen
-
Fanciulli, Maurizio
SpringerLink (Online service)
- DOI
-
10.1186/s13046-016-0484-y
- URN
-
urn:nbn:de:1111-2017021111740
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Catena, Valeria
- Fanciulli, Maurizio
- SpringerLink (Online service)
Ähnliche Objekte (12)
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Clinical development of mTOR inhibitors in breast cancer
Practical considerations for the use of mTOR inhibitors
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Perfect match: mTOR inhibitors and tuberous sclerosis complex
mTOR Inhibitors and Calcineurin Inhibitors Do Not Affect Adhesion Molecule Expression of Human Macro- and Microvascular Endothelial Cells
Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
mTOR inhibitors: A novel class of anti-cancer agents
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Clinical development of mTOR inhibitors in breast cancer
Practical considerations for the use of mTOR inhibitors
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Perfect match: mTOR inhibitors and tuberous sclerosis complex
mTOR Inhibitors and Calcineurin Inhibitors Do Not Affect Adhesion Molecule Expression of Human Macro- and Microvascular Endothelial Cells
Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
mTOR inhibitors: A novel class of anti-cancer agents
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Clinical development of mTOR inhibitors in breast cancer
Practical considerations for the use of mTOR inhibitors
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Perfect match: mTOR inhibitors and tuberous sclerosis complex
mTOR Inhibitors and Calcineurin Inhibitors Do Not Affect Adhesion Molecule Expression of Human Macro- and Microvascular Endothelial Cells
Determinants of mTOR inhibitor therapy in AIDS-associated malignancies